Amy Pashler read a BSc degree in Biochemistry and Genome Science at the University of Portsmouth, graduating in 2013. She is currently in the first year of her PhD funded by the University of Brighton, focusing on the genetic basis of osteosarcoma, with particular emphasis on the role of the exoribonuclease, XRN1. Amy has previously worked at the German Cancer Research Centre in Heidelberg, Germany, where she was involved in looking at alternative drug therapies for pancreatic cancer. She has worked with Prof Sarah Newbury as a Research Technician for 2 years, and was involved in studying the presence of prognostic biomarkers in melanoma. Her primary research interests are gene regulation and how it relates to the development of cancer.